The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March. Still, the agency warned it's not clear whether any of these will work against the deadly virus that has...
An increase in the number of prescriptions of a powerful antipsychotic drug for conditions not...
Some lots of the product, called Mylan-Nitro Sublingual Spray 0.4 mg Per Metered Dose, are...
Access to potentially life-extending cancer drugs varies significantly in different regions of...
Health Canada says it has approved a plan by GlaxoSmithKline to fix contamination problems it has been experiencing at its Ste. Foy, Que., flu vaccine production plant. The department says GSK's action plan and the timelines proposed in it are satisfactory.
A recent Health Canada inspection of the country's only flu vaccine production plant identified 10 issues that need to be addressed, a report from the regulatory agency reveals. The summary report of the June inspection said none of the problems found poses a critical risk to public health, but seven fall into the major observation category.
Biogen Idec announced that Health Canada has approved ALPROLIX ™, for the control and prevention of bleeding episodes and routine prophylaxis in adults, and children aged 12 and older, with hemophilia B.
WHITEHOUSE STATION, N.J. (AP) — Merck & Co. says it's won its first approval for its new immunotherapy tablet for grass allergies, from regulators in Canada. The drug, called Grastek, gradually reduced allergic reactions to grass pollen, by desensitizing the immune system to the substance triggering the allergic reaction.
The drug Sovaldi (sofosbuvir) is to be taken in combination with older medications to treat the main forms of hepatitis C, which is caused by a blood-borne virus. Left untreated, the disease can lead to liver failure, cirrhosis and cancer.
Canadian Study: Patient Suffering Could Be Reduced by Accepting European or U.S. Prescription Drug ApprovalsSeptember 25, 2013 7:59 am | News | Comments
Canadian patients are denied the health benefits of many new medicines for months, if not years, waiting for their government to duplicate approvals already provided in other jurisdictions, concludes a new study published today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.
Erivedge™ was recently approved in Canada for the treatment of adult patients with histologically confirmed metastatic basal cell carcinoma or locally advanced basal cell carcinoma inappropriate for surgery or radiotherapy. Basal cell carcinoma (BCC) is the most common type of canceri, and accounts for 80 per cent of all skin cancer cases.
On May 30, 2013, Health Canada approved Xtandi for the treatment of patients with metastatic castration-resistant prostate cancer, or mCRPC, who have received prior docetaxel therapy (chemotherapy medication). The announcement was made today by Astellas Pharma Canada, Inc., the Canadian subsidiary of Tokyo-based Astellas Pharma, Inc.
Health Canada says three companies are voluntarily recalling all lots of the antipsychotic drug quetiapine. A Health Canada news release says it's due to potential contamination with the antibiotic product clindamycin during the manufacturing process.
PERJETA (pertuzumab), in combination with the current standard of care, HERCEPTIN® (trastuzumab) and docetaxel chemotherapy, is approved for the treatment of patients with HER2-positive metastatic breast cancer (mBC) who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
Health Canada has come up with a temporary solution to eliminate a jurisdictional grey area that may have contributed to over 1,200 patients receiving diluted chemotherapy drugs. Officials with the federal health agency will discuss the proposal in a conference call Friday with top health bureaucrats from all the provinces and territories.
Health Canada is advising Canadians that Novartis Consumer Health Canada Inc. is conducting a voluntary recall of 17 products (see chart below) as the child resistant mechanism of the bottle cap can fail. As a result, children may be able to open the bottle and ingest the product. The ingredients of the affected products may be harmful to children.
Arbonne International Distribution Inc. is voluntarily recalling one lot (lot 043904) of its RE9 Advanced for Men Facial Moisturizer SPF 20 Sunscreen due to microbial contamination. Product testing undertaken by the company detected bacteria (Aerococcus viridans) that may pose serious...
New standard for hospitals on reporting adverse drug reactions released today - Standard will be supported by marketing activities to boost reporting by health professionalsJanuary 30, 2013 6:21 am | by Health Canada | News | Comments
The Honourable Leona Aglukkaq, Minister of Health, today congratulated Accreditation Canada on including, for the first time, guidance on the reporting of adverse drug reactions in its latest Medication Management Standards for health care facilities, including hospitals.
Health Canada is informing Canadians that Prestige Brands is conducting a voluntary recall of one lot (lot 3742) of its Infants Little Remedies for Fevers after testing conducted by the company indicated some bottles may contain less than the claimed amount of acetaminophen.
Health Canada is informing Canadians of a labelling update for all cholesterol-lowering drugs (also known as statins) regarding the risk of increased blood sugar levels and a small increased risk of diabetes among patients already at risk for the disease.
New Labelling Information for all Botulinum Toxin Products: Botox/Botox Cosmetic, Dysport, Xeomin/Xeomin Cosmetic and MyoblocJanuary 21, 2013 7:21 am | by Health Canada | News | Comments
In order to help prevent medication errors with the use of botulinum toxin products currently available on the Canadian market, Health Canada will be requesting that all manufacturers of these products revise their product labels to reflect that each product has its own individual potency...
Mould can develop between the removable seat cushion and the hard plastic frame of the sleeper. The advisory affects Model R6070, which was the only model sold in Canada. While mould is not present when the product is purchased, it can grow when the product remains wet or moist, or is...
Almost everyone makes New Year’s resolutions at some point in their lives. Many Canadians each year resolve to eat better and become more physically active. If these are among your goals for 2013, learning more about Canada’s Food Guide will help you and your family on your way to...
Four unauthorized natural health products have been removed from sale as they may pose serious risks to the health of Canadians. The "ExtenZe" products (shown below) are promoted as sexual enhancement products and contain ingredients that legally require they be sold with a prescription in Canada.
Pradaxa (dabigatran, previously called Pradax): not to be used in patients with artificial heart valvesDecember 21, 2012 3:20 pm | by Health Canada | News | Comments
Health Canada is advising health care professionals and the public that, based on new information, the blood-thinning drug Pradaxa is not to be used in patients with artificial heart valves (also known as prosthetic heart valves) due to the risk of strokes, bleeding, heart attacks, and...
Health Canada's testing of "EV Princess Express Peeling", "EV Princess Extra Whitening Night Cream" and "Ling Zhi BB Whitening Cream" identified levels of mercury that are beyond the allowable limit set by Health Canada. All three are unauthorized natural health products promoted as facial creams.
Harper Government Applauds One of the Largest Ever Public-Private Investments in Health Research - The Chagnon Family and the Azrieli Foundation commit $46 million to Support...December 21, 2012 9:21 am | by Health Canada | News | Comments
Today the Honourable Leona Aglukkaq, Minister of Health, and the Honourable Jim Flaherty, Minister of Finance, are pleased to congratulate the Chagnon Family and the Azrieli Foundation for partnering with Brain Canada and the Government of Canada, through the Canada Brain Research Fund,...
Further to our previous communications, Health Canada is advising Canadians that three additional unauthorized products promoted for weight loss have been seized from the "Cube Inc." store in Richmond, B.C.
- Page 1